Human cloning, regenerative therapy need regulation: Nobel laureates
05/08/2018 08:51 AM
While stem cell research holds potential for understanding and treating diseases, regulation of its application is of equal importance in view of the unscrupulous marketing tactics touting regenerative therapy and the progress being made toward human cloning, Nobel Prize-winning scientists said in Taipei recently.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
GlobalWafers opens advanced 12-inch wafer plant in northern Italy
10/15/2025 09:36 PM - Society
Youtuber Holger Chen bailed over 'behead the president' remark
10/15/2025 09:16 PM - Sports
Jeffrey Koo Jr. seeks WBSC vice presidency to boost Asian baseball
10/15/2025 08:33 PM - Cross-Strait
Ex-airline employee indicted over attempt to obtain MAC research for China
10/15/2025 08:25 PM - Business
Hon Hai's market cap soars 850 times since TWSE listing
10/15/2025 08:20 PM